Direct-to-consumer advertising of genetics testing, an increasingly prevalent phenomenon, is poorly regulated and fraught with potential pitfalls for patients and physicians.
From 1Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts.
See related article on page 1392.
Corresponding author: Dr. Erin E. Tracy, Massachusetts General Hospital, Vincent Obstetrics and Gynecology, 55 Fruit Street, 406 Founders House, Boston, MA 02114; e-mail: EETracy@partners.org.
Financial Disclosure The author has no potential conflicts of interest to disclose.